Skip to main content

Congestive Heart Failure News (Page 6)

AHA News: 38-Year-Old Has Had 3 Hearts: 'It's a Third Chance'

WEDNESDAY, May 31, 2023 (American Heart Association News) – Melanie Wickersheim has no memory of the first time her heart gave her trouble. She was an infant, and her pediatric myocarditis – an i...

Quadriceps Strength Linked to Lower Risk for Heart Failure After AMI

FRIDAY, May 26, 2023 – A higher level of quadriceps isometric strength (QIS) is associated with a lower risk for developing heart failure after acute myocardial infarction (AMI), according to a...

Addition of GLP1-RA Tied to Lower MACE, Heart Failure Risk in Those With Diabetes

FRIDAY, May 12, 2023 – For individuals with diabetes without preexisting cardiovascular disease, the addition of glucagon-like peptide 1 receptor agonists (GLP1-RA) is associated with a lower risk...

FDA Approves Entresto (sacubitril/valsartan) for Heart Failure

July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...

FDA Medwatch Alert: Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 mg, 20 mL, Single-dose fliptop vial, (NDC 0409-2344-02), Lot 27-352-DK. (NDC and lot...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, Coumadin, spironolactone, triamcinolone, Metoprolol Succinate ER, carvedilol, diltiazem, view more... Lasix, Entresto, furosemide, bisoprolol, valsartan, Farxiga, Jardiance, ramipril, digoxin, prazosin, Diovan, nitroglycerin, Coreg